7.54
-0.28
(-3.58%)
As of 10:32:08 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
--
--
18,943
Operating Expense
196,919
196,919
190,649
132,137
86,897
Operating Income
-196,919
-196,919
-190,649
-132,137
-67,954
Net Non Operating Interest Income Expense
29,660
29,660
21,627
6,611
477
Other Income Expense
-199
-199
-201
276,842
-8
Pretax Income
-167,458
-167,458
-169,223
151,316
-67,485
Tax Provision
117
117
-14,122
42,121
--
Net Income Common Stockholders
-167,383
-167,383
-153,162
111,214
-65,570
Diluted NI Available to Com Stockholders
-167,383
-167,383
-153,162
111,214
-65,570
Basic EPS
-2.78
--
-3.21
2.46
-1.52
Diluted EPS
-2.78
--
-3.21
2.38
-1.52
Basic Average Shares
53,771
--
41,550
45,164
43,077.33
Diluted Average Shares
53,771
--
41,550
46,640
43,077.33
Total Operating Income as Reported
-196,919
-196,919
-191,089
144,648
-67,954
Total Expenses
196,919
196,919
190,649
132,137
86,897
Net Income from Continuing & Discontinued Operation
-167,383
-167,383
-153,162
111,214
-65,570
Normalized Income
-167,383
-167,383
-152,758.74
-88,597.09
-65,570
Interest Income
29,660
29,660
21,627
6,611
477
Net Interest Income
29,660
29,660
21,627
6,611
477
EBIT
-196,919
-196,919
-190,649
-132,137
-67,954
EBITDA
-196,613
-196,613
-190,339
-132,044
-67,901
Reconciled Depreciation
306
306
310
93
53
Net Income from Continuing Operation Net Minority Interest
-167,383
-167,383
-153,162
111,214
-65,570
Total Unusual Items Excluding Goodwill
--
--
-440
276,785
--
Total Unusual Items
--
--
-440
276,785
--
Normalized EBITDA
-196,613
-196,613
-189,899
-408,829
-67,901
Tax Rate for Calcs
0
0
0
0
--
Tax Effect of Unusual Items
--
--
-36.74
76,973.91
--
12/31/2021 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IDYA IDEAYA Biosciences, Inc.
14.90
-8.87%
DNTH Dianthus Therapeutics, Inc.
16.04
-10.19%
BCAX Bicara Therapeutics Inc.
12.46
-6.03%
KYMR Kymera Therapeutics, Inc.
24.29
-7.85%
NUVL Nuvalent, Inc.
69.36
-1.56%
DSGN Design Therapeutics, Inc.
3.5000
-7.65%
PTGX Protagonist Therapeutics, Inc.
46.04
-4.48%
ATXS Astria Therapeutics, Inc.
5.15
-6.70%
IPSC Century Therapeutics, Inc.
0.4466
-4.99%
KYTX Kyverna Therapeutics, Inc.
1.9700
-8.37%